Salpingectomy as standard at hysterectomy? A Danish cohort study, 1977-2010

BMJ Open

Volumn 3, Issue 6, 2013, Pages

  Guldberg, Rikke ^a   Wehberg, Sonja ^a   Skovlund, Charlotte Wessel ^b   Mogensen, Ole ^a   Lidegaard, Øjvind ^b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DENMARK; FEMALE; FEMALE STERILIZATION; FOLLOW UP; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; SALPINGECTOMY; UTERINE TUBE;

EID: 84880425412     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-002845     Document Type: Article

References (29)

1. Anon. [Danish Hysterectomy Database, Annual Report 2011] [Danish]. https://www.sundhed.dk/content/cms/69/1869-hysterektomi2011.pdf (accessed 24 Feb 2013).
2. Dar P, Sachs GS, Strassburger D, et al. Ovarian function before and after salpingectomy in artificial reproductive technology patients. Hum Reprod 2000;15:142-4. (Pubitemid 30035115)
3. Sezik M, Ozkaya O, Demir F, et al. Total salpingectomy during abdominal hysterectomy: effects on ovarian reserve and ovarian stromal blood flow. J Obstet Gynaecol Res 2007;33:863-9. (Pubitemid 350086521)
4. Ghezzi F, Cromi A, Siesto G, et al. Infectious morbidity after total laparoscopic hysterectomy: does concomitant salpingectomy make a difference? BJOG 2009;116:589-93.
5. Basu D, Ward SJ. Post-hysterectomy fallopian tube prolapse-a diagnostic pitfall. J Obstet Gynaecol 2007;27:324. (Pubitemid 46676390)
6. Singla A. An unusual case of torsion hydrosalpinx after hysterectomy: a case report. Aust N Z J Obstet Gynaecol 2007;47:256-7. (Pubitemid 46909311)
7. Timor-Tritsch IE, Monteagudo A, Tsymbal T. Three-dimensional ultrasound inversion rendering technique facilitates the diagnosis of hydrosalpinx. J Clin Ultrasound 2010;38:372-6.
8. Morse AN, Hammer RA, Walter AJ, et al. Does hysterectomy without adnexectomy in patients with prior tubal interruption increase the risk of subsequent hydrosalpinx? Am J Obstet Gynecol 2002;187:1483-6. (Pubitemid 36026674)
9. Repasy I, Lendvai V, Koppan A, et al. Effect of the removal of the fallopian tube during hysterectomy on ovarian survival: the orphan ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2009;144:64-7.
10. Morse AN, Schroeder CB, Magrina JF, et al. The risk of hydrosalpinx formation and adnexectomy following tubal ligation and subsequent hysterectomy: a historical cohort study. Am J Obstet Gynecol 2006;194:1273-6.
11. Piek JM, Van Diest PJ, Zweemer RP, et al. Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer. J Pathol 2001;195:451-6. (Pubitemid 33069670)
12. Kindelberger DW, Lee Y, Miron A, et al. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. Am J Surg Pathol 2007;31:161-9. (Pubitemid 46175016)
13. Carlson JW, Miron A, Jarboe EA, et al. Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention. J Clin Oncol 2008;26:4160-5.
14. Przybycin C, Kurman R, Ronnett B, et al. Are all pelvic (non-uterine) serous carcinomas of tubal origin? Am J Surg Pathol 2010;34:1407-16.
15. Marquez RT, Baggerly KA, Patterson AP, et al. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon. Clin Cancer Res 2005;11:6116-26. (Pubitemid 41262937)
16. Tone AA, Begley H, Sharma M, et al. Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma. Clin Cancer Res 2008;14:4067-78.
17. Salvador S, Gilks B, Köbel M, et al. The fallopian tube: primary site of most pelvic high-grade serous carcinomas. Int J Gynecol Cancer 2009;19:58-64.
18. Anon. World Contraceptive Use 2005 [Internet]. http://www.un.org/esa/ population/publications/contraceptive2005/2005-World-Contraceptive-files/ WallChart-WCU2005.pdf (accessed 28 Jan 2013).
19. Lawrie T, Nardin J, Kulier R, et al. Techniques for the interruption of tubal patency for female sterilisation. Cochrane Database Syst Rev 2011;(2):CD003034.
20. Kjer JJ. [Sterilisations of women] [Danish]. Ugeskr Laeger 2004;166:696-7.
21. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health 2011;39:30-3.
22. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med 2007;26:2389-430. (Pubitemid 46730255)
23. Kjærgaard J, Haunstrup I, Lykke B, et al. Validity of diagnoses of and operations for nonmalignant gynecological conditions in the Danish National Hospital Registry. J Clin Epidiomol 2002;55:137-42. (Pubitemid 34051527)
24. Andersen T, Madsen M, Loft A. [Validity of surgical information from the Danish National Patient Registry with special attention to the analysis of regional variations in hysterectomy rates] [Danish]. Ugeskr Laeger 1987;149:2420-2.
25. Blank S. Prophylactic and risk-reducing bilateral salpingo-oophorectomy: recommendations based on risk of ovarian cancer. Obstet Gynecol 2011;117:404.
26. Dietl J, Wischhusen J, Häusler SFM. The post-reproductive fallopian tube: better removed? Hum Reprod 2011;26:2918-24.
27. The society of gynecologic oncology of Canada. GOC statement regarding Salpingectomy and Ovarian Cancer Prevention 2011. http://www.g-o-c.org/uploads/ 11sept15-gocevidentiarystatement-final-en.pdf (accessed 5 Apr 2013).
28. Greene MH, Mai PL, Schwartz PE. Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers? Am J Obstet Gynecol 2011;204:19.e1-6.
29. Westgren M. Prevention of ovarian cancer-let's do something. Acta Obstet Gynecol Scand 2012;91:1009-10.